SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (2575)7/27/2001 10:04:10 PM
From: scaram(o)ucheRead Replies (1) of 4974
 
Friday July 27, 6:30 pm Eastern Time

Press Release

SOURCE: Exelixis, Inc.

Exelixis Files Shelf Registration Statement

SOUTH SAN FRANCISCO, Calif., July 27 /PRNewswire/ -- Exelixis, Inc. (Nasdaq: EXEL - news) today announced that it
has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission, which will permit the
company, from time to time, to offer and sell common stock, up to a value of $150 million. The company filed the registration
statement to gain additional flexibility in accessing capital markets for general corporate purposes, including the continued
development and manufacturing of the recently acquired rebeccamycin analogue in ongoing Phase I and I/II cancer studies,
expansion of drug discovery capabilities and other corporate purposes. (snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News